No, the ADNEX Model is Not the Same as IOTA—It is One Specific Tool Developed by the IOTA Group
The ADNEX (Assessment of Different NEoplasias in the adneXa) model is a mathematical risk prediction tool created by the International Ovarian Tumor Analysis (IOTA) group, but IOTA itself is a broader research consortium that has developed multiple classification systems and tools for evaluating adnexal masses. 1
Understanding the Relationship
IOTA is the Parent Organization
- IOTA (International Ovarian Tumor Analysis) is a multicenter research group that has developed evidence-based terminology, definitions, and multiple classification systems for adnexal mass evaluation
- The IOTA group has created several distinct tools, not just one model 1
IOTA Has Developed Multiple Tools
1. IOTA Simple Rules
- A pattern recognition system using 10 ultrasound features (5 benign "B-rules" and 5 malignant "M-rules")
- Cannot classify approximately 20% of cases (labeled as "inconclusive"), requiring expert evaluation
- Simpler to apply but less comprehensive 1
2. IOTA ADNEX Model
- A mathematical model that incorporates the 10 ultrasound features from Simple Rules
- Calculates specific risk percentages for different outcomes:
- Benign mass
- Borderline malignancy
- Stage I invasive cancer
- Stage II-IV invasive cancer
- Secondary metastatic cancer
- Provides continuous risk assessment rather than binary classification
- More complex but classifies all masses 1
3. IOTA Two-Step Strategy
- Uses modified Benign Descriptors followed by ADNEX model application
- Represents a sequential approach combining pattern recognition with mathematical modeling 2
Key Distinctions in Clinical Practice
Geographic Usage Patterns
- IOTA tools (particularly ADNEX) are widely used and validated in Europe
- North American practice has historically favored pattern recognition approaches over mathematical models
- This preference led to development of O-RADS (Ovarian-Adnexal Reporting and Data System), which incorporates IOTA terminology but uses a different risk stratification framework 1
Performance Characteristics
Recent evidence shows:
- ADNEX model demonstrates high sensitivity (78.8-93.9%) with excellent specificity (81.0-97.9%) for malignancy detection 3, 4
- ADNEX outperforms IOTA Simple Rules in diagnostic accuracy (AUC 0.958 vs 0.886) 4
- Both ADNEX and O-RADS show excellent discrimination (AUC >0.90), with ADNEX achieving slightly higher sensitivity 2
Clinical Application Considerations
When to Use ADNEX vs Other IOTA Tools
- Use ADNEX when you need specific risk percentages for surgical planning and patient counseling, particularly for distinguishing between different malignancy stages 1, 5
- Use Simple Rules for rapid bedside assessment when expert evaluation is available for inconclusive cases 4
- Consider the Two-Step Strategy when combining pattern recognition with mathematical modeling in tertiary centers 2
Common Pitfall to Avoid
Do not assume all IOTA-based assessments are equivalent—the Simple Rules, ADNEX model, and Two-Step Strategy have different classification capabilities, with ADNEX providing the most granular risk stratification but requiring more data input and calculation (typically via online application) 1, 4, 5